vs
Cytek Biosciences, Inc.（CTKB）与NLIGHT, INC.（LASR）财务数据对比。点击上方公司名可切换其他公司
NLIGHT, INC.的季度营收约是Cytek Biosciences, Inc.的1.3倍（$80.2M vs $62.1M），NLIGHT, INC.净利率更高（0.8% vs -70.9%，领先71.7%），NLIGHT, INC.同比增速更快（55.2% vs 8.1%），过去两年NLIGHT, INC.的营收复合增速更高（26.0% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
nLight Inc.是全球领先的高性能半导体激光器、光纤激光器及相关光学组件研发生产商，产品广泛应用于工业精密制造、航空航天与国防、医疗设备、前沿研究等核心领域，客户遍及北美、欧洲及亚太地区。
CTKB vs LASR — 直观对比
营收规模更大
LASR
是对方的1.3倍
$62.1M
营收增速更快
LASR
高出47.1%
8.1%
净利率更高
LASR
高出71.7%
-70.9%
两年增速更快
LASR
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $80.2M |
| 净利润 | $-44.1M | $645.0K |
| 毛利率 | 52.9% | 33.1% |
| 营业利润率 | -9.0% | 66.0% |
| 净利率 | -70.9% | 0.8% |
| 营收同比 | 8.1% | 55.2% |
| 净利润同比 | -557.1% | — |
| 每股收益（稀释后） | — | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBLASR
| Q1 26 | — | $80.2M | ||
| Q4 25 | $62.1M | $81.2M | ||
| Q3 25 | $52.3M | $66.7M | ||
| Q2 25 | $45.6M | $61.7M | ||
| Q1 25 | $41.5M | $51.7M | ||
| Q4 24 | $57.5M | $47.4M | ||
| Q3 24 | $51.5M | $56.1M | ||
| Q2 24 | $46.6M | $50.5M |
净利润CTKBLASR
| Q1 26 | — | $645.0K | ||
| Q4 25 | $-44.1M | $-4.9M | ||
| Q3 25 | $-5.5M | $-6.9M | ||
| Q2 25 | $-5.6M | $-3.6M | ||
| Q1 25 | $-11.4M | $-8.1M | ||
| Q4 24 | $9.6M | $-25.0M | ||
| Q3 24 | $941.0K | $-10.3M | ||
| Q2 24 | $-10.4M | $-11.7M |
毛利率CTKBLASR
| Q1 26 | — | 33.1% | ||
| Q4 25 | 52.9% | 30.7% | ||
| Q3 25 | 52.7% | 31.1% | ||
| Q2 25 | 52.3% | 29.9% | ||
| Q1 25 | 48.6% | 26.7% | ||
| Q4 24 | 58.5% | 2.4% | ||
| Q3 24 | 56.3% | 22.4% | ||
| Q2 24 | 54.6% | 23.5% |
营业利润率CTKBLASR
| Q1 26 | — | 66.0% | ||
| Q4 25 | -9.0% | -6.7% | ||
| Q3 25 | -17.6% | -10.9% | ||
| Q2 25 | -23.3% | -6.9% | ||
| Q1 25 | -36.1% | -18.6% | ||
| Q4 24 | 5.2% | -55.8% | ||
| Q3 24 | -8.2% | -21.0% | ||
| Q2 24 | -18.3% | -25.1% |
净利率CTKBLASR
| Q1 26 | — | 0.8% | ||
| Q4 25 | -70.9% | -6.0% | ||
| Q3 25 | -10.5% | -10.3% | ||
| Q2 25 | -12.2% | -5.8% | ||
| Q1 25 | -27.5% | -15.7% | ||
| Q4 24 | 16.8% | -52.7% | ||
| Q3 24 | 1.8% | -18.4% | ||
| Q2 24 | -22.4% | -23.2% |
每股收益（稀释后）CTKBLASR
| Q1 26 | — | $0.01 | ||
| Q4 25 | — | $-0.10 | ||
| Q3 25 | — | $-0.14 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | — | $-0.16 | ||
| Q4 24 | — | $-0.52 | ||
| Q3 24 | — | $-0.21 | ||
| Q2 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $298.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $429.2M |
| 总资产 | $461.5M | $515.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBLASR
| Q1 26 | — | $298.2M | ||
| Q4 25 | $90.9M | $98.7M | ||
| Q3 25 | $93.3M | $81.1M | ||
| Q2 25 | $75.5M | $78.8M | ||
| Q1 25 | $95.3M | $82.2M | ||
| Q4 24 | $98.7M | $65.8M | ||
| Q3 24 | $162.3M | $41.5M | ||
| Q2 24 | $177.9M | $49.4M |
股东权益CTKBLASR
| Q1 26 | — | $429.2M | ||
| Q4 25 | $341.7M | $226.7M | ||
| Q3 25 | $378.6M | $218.5M | ||
| Q2 25 | $377.6M | $216.0M | ||
| Q1 25 | $379.6M | $212.8M | ||
| Q4 24 | $395.7M | $216.4M | ||
| Q3 24 | $385.5M | $235.3M | ||
| Q2 24 | $389.1M | $239.5M |
总资产CTKBLASR
| Q1 26 | — | $515.7M | ||
| Q4 25 | $461.5M | $315.2M | ||
| Q3 25 | $494.9M | $298.7M | ||
| Q2 25 | $493.3M | $295.3M | ||
| Q1 25 | $482.6M | $290.0M | ||
| Q4 24 | $499.5M | $270.2M | ||
| Q3 24 | $491.2M | $291.3M | ||
| Q2 24 | $483.7M | $294.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBLASR
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $17.5M | ||
| Q3 25 | $-3.9M | $5.2M | ||
| Q2 25 | $108.0K | $-1.4M | ||
| Q1 25 | $-125.0K | $-20.0K | ||
| Q4 24 | $2.0M | $-3.9M | ||
| Q3 24 | $13.2M | $-5.6M | ||
| Q2 24 | $6.2M | $-4.2M |
自由现金流CTKBLASR
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $15.9M | ||
| Q3 25 | $-4.6M | $2.4M | ||
| Q2 25 | $-1.5M | $-3.8M | ||
| Q1 25 | $-974.0K | $-2.3M | ||
| Q4 24 | $1.1M | $-6.5M | ||
| Q3 24 | $12.2M | $-7.2M | ||
| Q2 24 | $5.2M | $-6.4M |
自由现金流率CTKBLASR
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 19.6% | ||
| Q3 25 | -8.7% | 3.7% | ||
| Q2 25 | -3.2% | -6.1% | ||
| Q1 25 | -2.3% | -4.5% | ||
| Q4 24 | 1.9% | -13.7% | ||
| Q3 24 | 23.7% | -12.9% | ||
| Q2 24 | 11.0% | -12.6% |
资本支出强度CTKBLASR
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 2.0% | ||
| Q3 25 | 1.3% | 4.2% | ||
| Q2 25 | 3.5% | 3.9% | ||
| Q1 25 | 2.0% | 4.4% | ||
| Q4 24 | 1.6% | 5.5% | ||
| Q3 24 | 2.0% | 2.9% | ||
| Q2 24 | 2.3% | 4.2% |
现金转化率CTKBLASR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LASR
| Products | $58.2M | 73% |
| Development | $22.0M | 27% |
